Biosimilars: US FDA Considering ‘Guardrails’ To Prevent Misinformation

 
• By Sue Sutter
  
Guardrail_Road
Communications about biosimilars may require some guardrails. • Source: Shutterstock

More from Biosimilars

More from Biosimilars & Generics